Kidney cancer: bisphosphonates in the era of antiangiogenic targeted therapy. [electronic resource]
- Nature reviews. Urology Jun 2014
- 315-6 p. digital
Publication Type: Journal Article
1759-4820
10.1038/nrurol.2014.120 doi
Angiogenesis Inhibitors--administration & dosage Bone Neoplasms--drug therapy Carcinoma, Renal Cell--drug therapy Diphosphonates--administration & dosage Evidence-Based Medicine Humans Kidney Neoplasms--drug therapy Pain--drug therapy Randomized Controlled Trials as Topic Treatment Outcome